Strictly Laboratory Research Use Only: Not approved for human or clinical consumption. HPLC Purity Tested (≥99%).
- In Stock (120 vials available)
- Face Cream
Purity:
RETATRUTIDE (RETA) 10 MG/ML
Vial Size / Concentration:
$120.00
/ vial
Triple-Receptor Metabolic Research Peptide
Retatrutide is an investigational peptide studied for its simultaneous activity at three metabolic hormone receptors: GLP-1, GIP, and glucagon receptors. This triple-agonist mechanism distinguishes it from single- and dual-receptor incretin compounds.
Research has examined retatrutide’s effects on appetite regulation, energy intake, glucose metabolism, insulin signaling, lipid metabolism, and energy expenditure. The glucagon-receptor component is of particular research interest because it may influence energy expenditure and hepatic metabolism alongside the incretin effects of GLP-1 and GIP receptor activation.
Clinical research has reported substantial changes in body weight and metabolic markers, while ongoing studies continue to evaluate efficacy, safety, and longer-term metabolic effects. Retatrutide remains an investigational compound and is not FDA-approved as of August 2026.
Research Focus: GLP-1 • GIP • Glucagon Receptors • Metabolic Signaling • Appetite Regulation • Glucose Metabolism • Insulin Signaling • Energy Expenditure • Body-Weight Research
Concentration: Retatrutide — 10 mg/mL
RESEARCH USE ONLY NOT FOR HUMAN OR ANIMAL USE
CAS Number:
Molecular Formula:
Molecular Weight:
Appearance:
ISO 9001:2015 Verified Laboratory Compound
